{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:13Z","timestamp":1786998313224,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA 27469"],"award-info":[{"award-number":["CA 27469"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gynecologic Oncology Group Statistical Office","award":["CA 37517"],"award-info":[{"award-number":["CA 37517"]}]},{"name":"NRG Oncology","award":["1U10 CA180822"],"award-info":[{"award-number":["1U10 CA180822"]}]},{"name":"NRG Operations","award":["U10CA180868"],"award-info":[{"award-number":["U10CA180868"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ygyno.2016.11.033","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T02:48:16Z","timestamp":1484275696000},"page":"459-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer \u2013 An NRG oncology\/Gynecologic Oncology Group study"],"prefix":"10.1016","volume":"144","author":[{"given":"Vivian E.","family":"von Gruenigen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Beumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Lankes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Hurria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Mannel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Rizack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Landrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Salani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles Alvarez","family":"Secord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gini","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.11.033_bb0005","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1200\/JCO.2014.55.3073","article-title":"Breast and ovarian cancer in the older woman","volume":"32","author":"Tew","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2015.03.052","article-title":"Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer","volume":"137","author":"Joseph","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2016.11.033_bb0015","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.11.033_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/2229-3485.86879","article-title":"Patient-reported outcomes: a new era in clinical research","volume":"2","author":"Deshpande","year":"2011","journal-title":"Perspect Clin. Res."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0025","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2001.19.6.1809","article-title":"Reliability and validity of the functional assessment of cancer therapy-ovarian","volume":"19","author":"Basen-Engquist","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1525-1438.2003.13603.x","article-title":"Psychometric evaluation of the functional assessment of cancer therapy\/gynecologic oncology group \u2013 neurotoxicity (Fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy","volume":"13","author":"Calhoun","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.033_bb0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/geronj\/36.4.428","article-title":"The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire","volume":"36","author":"Fillenbaum","year":"1981","journal-title":"J. Gerontol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0040","series-title":"Measuring Functioning and well-Being: The Medical Outcomes Study Approach","author":"Stewart","year":"1992"},{"key":"10.1016\/j.ygyno.2016.11.033_bb0045","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1051\/ject\/201042075","article-title":"In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion","volume":"42","author":"Colville","year":"2010","journal-title":"J. Extra Corpor. Technol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1570-0232(02)00659-1","article-title":"Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma","volume":"783","author":"Parise","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s002800050408","article-title":"A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curve","volume":"37","author":"Ghazal-Aswad","year":"1996","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0065","article-title":"Validation of paclitaxel limited sampling strategies","author":"Kearns","year":"1997","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10549-012-2253-8","article-title":"Social networks, social support, and burden in relationships, and mortality after breast cancer diagnosis in the Life After Breast Cancer Epidemiology (LACE) study","volume":"137","author":"Kroenke","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1200\/JCO.2006.07.3494","article-title":"Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Wenzel","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2011.11.032","article-title":"The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study","volume":"124","author":"von Gruenigen","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0085","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jgo.2016.02.007","article-title":"Geriatric assessment with management in cancer care: current evidence and potential mechanisms for future research","volume":"7","author":"Magnuson","year":"2016","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0090","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jnci\/djs285","article-title":"Use of geriatric assessment for older adults in the oncology setting: a systematic review","volume":"104","author":"Puts","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/annonc\/mdt386","article-title":"An update on a systematic review of the use of geriatric assessment for older adults in oncology","volume":"25","author":"Puts","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0100","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/annonc\/mdt360","article-title":"Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial","volume":"24","author":"Falandry","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0105","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/annonc\/mdi368","article-title":"Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study","volume":"16","author":"Freyer","year":"2005","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.11.033_bb0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2016.03.018","article-title":"Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: results of a pooled analysis of three GINECO phase II trials","volume":"143","author":"Tinquaut","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/annonc\/mdl400","article-title":"Carboplatin\/cyclophosphamide or carboplatin\/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens","volume":"18","author":"Tredan","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0120","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2013.280416","article-title":"Improving the quality of cancer care in an aging population: recommendations from an IOM report","volume":"310","author":"Hurria","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2016.11.033_bb0125","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1200\/JCO.2015.63.0319","article-title":"Improving the evidence base for treating older adults with cancer: American Society of Clinical Oncology Statement","volume":"33","author":"Hurria","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0130","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1200\/JCO.2010.30.6985","article-title":"Implementing a geriatris assessment in cooperative group clinical cancer trials: CALGB 360401","volume":"29","author":"Hurria","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jnci\/djs145","article-title":"Biological, clinical, and psychosocial correlates at the interface of cancer and aging research","volume":"104","author":"Dale","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0140","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1200\/JCO.2013.55.0418","article-title":"Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations","volume":"32","author":"Hurria","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0145","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIc-IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/AOG.0000000000001196","article-title":"Ovarian cancer treatment and survival trends among women older than 65years of age in the United States, 1995\u20132008","volume":"127","author":"Lin","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2005.04.037","article-title":"Treatment patterns by decade of life in elderly women (> or =70years of age) with ovarian cancer","volume":"98","author":"Uyar","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/1097-0142(19940115)73:2<377::AID-CNCR2820730223>3.0.CO;2-#","article-title":"National survey of ovarian carcinoma. IV: patterns of care and related survival for older patients","volume":"73","author":"Hightower","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2016.11.033_bb0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ygyno.2011.06.031","article-title":"Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization","volume":"123","author":"Langstraat","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ygyno.2011.08.030","article-title":"Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer","volume":"123","author":"Thrall","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0175","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.1996.14.6.1895","article-title":"Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group","volume":"14","author":"Bookman","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0180","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s002800050919","article-title":"A single 24-hour plasma sample does not predict the carboplatin AUC from carboplatin-paclitaxel combinations or from a high-dose carboplatin-thiotepa-cyclophosphamide regimen","volume":"43","author":"Panday","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0185","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/0959-8049(95)00382-S","article-title":"Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients","volume":"31","author":"Peng","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2016.11.033_bb0190","first-page":"599","article-title":"Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion","volume":"1","author":"Ohtsu","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2016.11.033_bb0195","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1200\/JCO.2005.03.9289","article-title":"Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)","volume":"24","author":"Lichtman","year":"2006","journal-title":"J. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581631602X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581631602X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T14:41:13Z","timestamp":1692628873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581631602X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S009082581631602X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.033","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer \u2013 An NRG oncology\/Gynecologic Oncology Group study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}